STAT5B and breast carcinoma: The extensive mouse model data presented here suggest that in women a pregnancy may also cause preexisting early lesions to aberrantly and persistently activate STAT5, and chemoprevention targeting STAT5 activity may lower breast cancer risk in women who have had a late-age pregnancy as well as in those who have abnormally high levels of pSTAT5.